Zobrazeno 1 - 10
of 385
pro vyhledávání: '"Leiss, V."'
Autor:
Köhler D; Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany., Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Beichert L; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Killinger S; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Grothe D; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Kushwaha R; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Schröter A; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Roslan A; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany., Eggstein C; Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany., Focken J; Division of Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany., Granja T; Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany., Devanathan V; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany.; Department of Biology, Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati, 517507, India., Schittek B; Division of Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany., Lukowski R; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany., Weigelin B; Department of Preclinical Imaging and Radiopharmacy, Multiscale Immunoimaging, Eberhard Karls University, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, Tübingen, Germany., Rosenberger P; Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany., Beer-Hammer S; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany. sandra.beer-hammer@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, Tübingen, Germany. sandra.beer-hammer@uni-tuebingen.de.
Publikováno v:
Basic research in cardiology [Basic Res Cardiol] 2024 Oct; Vol. 119 (5), pp. 717-732. Date of Electronic Publication: 2024 May 30.
Autor:
Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany., Schönsiegel A; Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany., Gnad T; Institute of Pharmacology and Toxicology, University of Bonn, 53127, Bonn, Germany., Kerner J; Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany., Kaur J; Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany., Sartorius T; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany., Machann J; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany; Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tübingen, Germany., Schick F; Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology, University of Tübingen, Germany., Birnbaumer L; Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA; Institute of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires, Argentina., Häring HU; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany., Pfeifer A; Institute of Pharmacology and Toxicology, University of Bonn, 53127, Bonn, Germany., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research, University of Tübingen, 72074, Tübingen, Germany. Electronic address: bernd.nuernberg@uni-tuebingen.de.
Publikováno v:
Molecular metabolism [Mol Metab] 2024 Apr; Vol. 82, pp. 101910. Date of Electronic Publication: 2024 Mar 02.
Autor:
Schröper T; Center of Pharmacology, Department II, University of Cologne and University Hospital Cologne, Cologne, Germany.; Department of Internal Medicine III, University Hospital of Cologne, Cologne, Germany and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Mehrkens D; Department of Internal Medicine III, University Hospital of Cologne, Cologne, Germany and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.; Centre for Molecular Medicine Cologne, CMMC, University of Cologne, Cologne, Germany., Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomics, and Interfaculty Centre for Pharmacogenomics and Drug Research, Eberhard Karls Universität, Tübingen, Germany., Tellkamp F; CECAD Research Centre Institute for Genetics, University of Cologne, Cologne, Germany., Engelhardt S; Institute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany., Herzig S; Center of Pharmacology, Department II, University of Cologne and University Hospital Cologne, Cologne, Germany.; TH Köln-University of Applied Sciences, Cologne, Germany., Birnbaumer L; Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, North Carolina, USA.; Institute of Biomedical Research, School of Medical Sciences, Catholic University of Buenos Aires, Buenos Aires, Argentina., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomics, and Interfaculty Centre for Pharmacogenomics and Drug Research, Eberhard Karls Universität, Tübingen, Germany., Matthes J; Center of Pharmacology, Department II, University of Cologne and University Hospital Cologne, Cologne, Germany. jan.matthes@uni-koeln.de.
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Apr; Vol. 397 (4), pp. 2401-2420. Date of Electronic Publication: 2023 Oct 16.
Autor:
Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, D-72074 Tübingen, Germany. Electronic address: bernd.nuernberg@uni-tuebingen.de., Beer-Hammer S; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, D-72074 Tübingen, Germany., Reisinger E; Gene Therapy for Hearing Impairment Group, Department of Otolaryngology - Head & Neck Surgery, University of Tübingen Medical Center, Elfriede-Aulhorn-Straße 5, D-72076 Tübingen, Germany., Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, D-72074 Tübingen, Germany.
Publikováno v:
Pharmacology & therapeutics [Pharmacol Ther] 2024 Mar; Vol. 255, pp. 108589. Date of Electronic Publication: 2024 Jan 29.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Castaneda-Vega S; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Beer-Hammer S; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Napieczyńska H; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Vuozzo M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Schmid AM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Zeng H; High Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany., He Y; High Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany., Kohlhofer U; Institute of Pathology and Neuropathology, Eberhard Karls University and Comprehensive Cancer Center, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Gonzalez-Menendez I; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Institute of Pathology and Neuropathology, Eberhard Karls University and Comprehensive Cancer Center, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Quintanilla-Martinez L; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Institute of Pathology and Neuropathology, Eberhard Karls University and Comprehensive Cancer Center, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Hempel JM; Department of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Gollasch M; Experimental and Clinical Research Center (ECRC), A Joint Cooperation Between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Department of Internal and Geriatric Medicine, University - Medicine Greifswald, Greifswald, Germany., Yu X; High Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany. Bernd.pichler@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany. Bernd.pichler@med.uni-tuebingen.de., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany. Bernd.nuernberg@uni-tuebingen.de.
Publikováno v:
Molecular imaging and biology [Mol Imaging Biol] 2023 Apr; Vol. 25 (2), pp. 363-374. Date of Electronic Publication: 2022 Sep 08.
Autor:
Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Piekorz RP; Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Vega SC; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany., Jacoby C; Institute of Molecular Cardiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Flögel U; Institute of Molecular Cardiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Pexa K; Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Schrader J; Institute of Molecular Cardiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, Tübingen, Germany., Beer-Hammer S; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, Tübingen, Germany., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Publikováno v:
Data in brief [Data Brief] 2022 Dec 25; Vol. 46, pp. 108851. Date of Electronic Publication: 2022 Dec 25 (Print Publication: 2023).
Autor:
Granja TF; Lusófona's Research Center for Biosciences & Health Technologies, CBIOS-Universidade, Campo Grande 376, 1749-024 Lisboa, Portugal.; Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Köhler D; Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Leiss V; Department of Pharmacology and Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research (ICePhA), Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Eggstein C; Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Nürnberg B; Department of Pharmacology and Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research (ICePhA), Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Rosenberger P; Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany., Beer-Hammer S; Department of Pharmacology and Experimental Therapy and Toxicology and Interfaculty Center of Pharmacogenomics and Drug Research (ICePhA), Tübingen University Hospital, Wilhelmstrasse 56, D-72074 Tübingen, Germany.
Publikováno v:
Cells [Cells] 2022 Sep 27; Vol. 11 (19). Date of Electronic Publication: 2022 Sep 27.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leiss V; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany., Reisinger E; Department of Otolaryngology-Head and Neck Surgery, Gene Therapy for Hearing Impairment Group, University of Tübingen, Medical Center, Elfriede-Aulhorn-Straße 5, 72076, Tübingen, Germany., Speidel A; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany., Beer-Hammer S; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany. sandra.beer-hammer@uni-tuebingen.de., Nürnberg B; Department of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, and ICePhA Mouse Clinic, University of Tübingen, Wilhelmstraße 56, 72074, Tübingen, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jul 12; Vol. 11 (1), pp. 14271. Date of Electronic Publication: 2021 Jul 12.